Jose Hilario, DPM
Foot & Ankle Surgery · Converse, TXNPI 1700806866
Payments from drug & device makers
Across 137 payments — averaging $61.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Triad Life Sciences Inc.$2K
- Paratek Pharmaceuticals, Inc.$2K
- Pylant Medical$1K
- Smith+Nephew$780
- Organogenesis Inc.$614
- Amgen$471
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$3464%
- Travel & lodging$1,89323%
- Food & beverage$4,97259%
- Education$1,20014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Triad Life Sciences Inc. | 11 | $2,356 |
| Paratek Pharmaceuticals, Inc. | 56 | $1,538 |
| Pylant Medical | 1 | $1,200 |
| Smith+Nephew | 18 | $780 |
| Organogenesis Inc. | 6 | $614 |
| Amgen(2 entities) | 8 | $471 |
| Acera Surgical, Inc. | 7 | $349 |
| Stryker | 5 | $196 |
| Sandoz | 11 | $187 |
| Paragon 28, Inc. | 1 | $149 |
| Misonix Inc | 1 | $120 |
| Merck | 1 | $99 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $97 |
| Pacira Pharmaceuticals Incorporated | 1 | $95 |
| Sebela Pharmaceuticals Inc. | 3 | $46 |
| Kerecis Limited | 2 | $40 |
| Nevro Corp. | 1 | $27 |
| Convatec Inc. | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$2,251
- NUZYRA$730
- RAYOS$375
- Apligraf$346
- Dermagraft$346
- Puraply/Affinity/NuTech$346
- KRYSTEXXA$248
- COLLAGENASE SANTYL$246
- Portfolio$149
- Restrata Wound Matrix$133
- PuraPly$125
- Versajet$125
- Affinity$125
- REGRANEX$122
- Stravix$117
How this compares
$8,411 in reported general payments places this provider in the 65th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 79 | $599 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $420 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $267 |
| Celecoxib | 11 | $192 |
| Terbinafine Hcl | 11 | $135 |
| Gabapentin | 12 | $123 |
| Meloxicam | 38 | $108 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Converse
- Richard PollakSan Antonio$6.1M
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Chad HowzeSan Antonio$2.4M
- Graham HamiltonEdinburg$2.1M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$972K
- Mark RobsonAustin$957K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.